Nuwellis Inc

NASDAQ:NUWEUnited States

NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

Contact Information

Headquarters

12988 Valley View RdEDEN PRAIRIE, MN, United States 55344-3657

Phone

952-345-4200

Fax

302-636-5454

Executives

Non-Executive Chairman of the Board

John Erb

President, Chief Executive Officer

Nestor Jaramillo

Chief Financial Officer

Robert Scott

Senior Vice President, Chief Compliance Officer, General Counsel, Company Secretary

Neil Ayotte

Chief Medical Officer

John Jefferies